Literature DB >> 3037997

E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system.

N A Watanabe, T Nagasu, K Katsu, K Kitoh.   

Abstract

E-0702, a new cephalosporin with a potent antipseudomonal action, was synthesized. In the study of the mode of action of this antibiotic in Escherichia coli, it was found that mutants which acquired resistance to E-0702 were isolated spontaneously and could be shown to be susceptible to its closely related derivatives, E-0702-060 and E-0702-061, and other representative beta-lactam antibiotics. In these mutants, no increased production of beta-lactamase was detectable. No apparent differences between the resistant mutants and the parental strains were observed in the affinity of E-0702 for penicillin-binding proteins. Furthermore, no significant reduction in or loss of both OmpF and OmpC porin proteins in the outer membrane was observed. The mutation was mapped to the tonB gene, which is known to be essential for the iron transport system of bacteria. The bactericidal action of E-0702 was rapidly expressed against iron-starved cells in which the iron transport system was induced, whereas the bactericidal action against iron-supplemented cells was ineffective. It is suggested that E-0702 is incorporated into bacterial cells as a chelator of iron via the tonB-dependent iron transport system, after which its strong and rapid bactericidal action is manifested.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037997      PMCID: PMC174766          DOI: 10.1128/AAC.31.4.497

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Triornithine-resistant strains of Escherichia coli. Isolation, definition, and genetic studies.

Authors:  Z Barak; C Gilvarg
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

2.  The inducible citrate-dependent iron transport system in Escherichia coli K12.

Authors:  G E Frost; H Rosenberg
Journal:  Biochim Biophys Acta       Date:  1973-11-30

3.  Comparison of assay techniques for beta-lactamase activity.

Authors:  G W Ross; K V Chanter; A M Harris; S M Kirby; M J Marshall; C H O'Callaghan
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

4.  An additional step in the transport of iron defined by the tonB locus of Escherichia coli.

Authors:  C C Wang; A Newton
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

5.  Enterobactin, an iron transport compound from Salmonella typhimurium.

Authors:  J R Pollack; J B Neilands
Journal:  Biochem Biophys Res Commun       Date:  1970-03-12       Impact factor: 3.575

6.  A model for three-point analysis of random general transduction.

Authors:  T T Wu
Journal:  Genetics       Date:  1966-08       Impact factor: 4.562

7.  A direct spectrophotometric assay and determination of Michaelis constants for the beta-lactamase reaction.

Authors:  A Samuni
Journal:  Anal Biochem       Date:  1975-01       Impact factor: 3.365

8.  Solubilization of the cytoplasmic membrane of Escherichia coli by Triton X-100.

Authors:  C A Schnaitman
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

9.  Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.

Authors:  C Filip; G Fletcher; J L Wulff; C F Earhart
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

10.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  35 in total

1.  In vitro antibacterial activity of KP-736, a new cephem antibiotic.

Authors:  T Maejima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  In vitro activity of a catechol-substituted cephalosporin, GR69153.

Authors:  R Wise; J M Andrews; J P Ashby; D Thornber
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  Evaluation of growth promotion and inhibition from mycobactins and nonmycobacterial siderophores (Desferrioxamine and FR160) in Mycobacterium aurum.

Authors:  S Bosne-David; L Bricard; F Ramiandrasoa; A DeRoussent; G Kunesch; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.

Authors:  M E Erwin; R N Jones; M S Barrett; B M Briggs; D M Johnson
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 5.  Transport of iron across the outer membrane.

Authors:  V Braun; K Günter; K Hantke
Journal:  Biol Met       Date:  1991

6.  Killing of gram-negative bacteria by lactoferrin and lysozyme.

Authors:  R T Ellison; T J Giehl
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

7.  Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system.

Authors:  P Silley; J W Griffiths; D Monsey; A M Harris
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

8.  KCa(H2 O)2 [FeIII (CN)6 ]⋅H2 O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus.

Authors:  Zhongxia Wang; Bing Yu; Huda Alamri; Sriramakrishna Yarabarla; Min-Ho Kim; Songping D Huang
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-02       Impact factor: 15.336

9.  In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.

Authors:  S Nakagawa; M Sanada; K Matsuda; T Hashizume; Y Asahi; R Ushijima; N Ohtake; N Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.

Authors:  M Y Kim; J I Oh; K S Paek; Y Z Kim; I C Kim; J H Kwak
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.